Founder, Chairman, Ora, Inc.
Ophthalmology
Dr. Mark B. Abelson, MD
|
|
Give Review
Mark B. Abelson practices Ophthalmology. He went to Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received 7 awards: "AAO Life Fellow", "ARVO Fellow", "Distinguished Alumnus Award", "Hall of Fame", "Service Award", "Honor Award" and "Fellow (FAAO)". Dr. Mark B. Abelson is a published doctor and has 101 publications published. The lastest was: 'The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.'
Publications
- Blink patterns and lid-contact times in dry-eye and normal subjects.
- The interblink interval in normal and dry eye subjects.
- Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis.
- Antihistamines in ocular allergy: are they all created equal?
- Personal profile. Mark B. Abelson, MD, CM, FRCSC.
- Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.
- Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.
- Diurnal variation of visual function and the signs and symptoms of dry eye.
- Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-cente...
- Dry eye in 2008.
- Vigabatrin: 2008 update.
- A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
- Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation ...
- Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
- The Ocular Protection Index.
- Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
- Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by...
- Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
- Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
- A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with ...
- Ocular allergy in pediatric practice.
- Pharmacology, clinical efficacy and safety of olopatadine hydrochloride.
- Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.
- Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.
- Methodologies for the study of ocular surface disease.
- Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or...
- Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.
- Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
- Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
- An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride.
- A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes.
- A review of olopatadine for the treatment of ocular allergy.
- Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a random...
- Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis.
- Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with se...
- Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.
- Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.
- Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes.
- Double-masked, randomized, placebo-controlled clinical study of the mast Cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge ...
- Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the c...
- One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in ...
- Ocular allergic disease: mechanisms, disease sub-types, treatment.
- Conjunctival allergen challenge: models in the investigation of ocular allergy.
- Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
- A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergi...
- Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension.
- Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, p...
- Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhi...
- Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.
- A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival...
- Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect.
- Evaluation of the time to "natural compensation" in normal and dry eye subject populations during exposure to a controlled adverse environment.
- Dry eye syndromes: diagnosis, clinical trials and pharmaceutical treatment--'improving clinical trials'.
- Alternative reference values for tear film break up time in normal and dry eye populations.
- Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model.
- Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjun...
- An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seaso...
- An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute ...
- Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis.
- The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model.
- Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic co...
- Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model.
- Alteration of mucin in human conjunctival epithelia in dry eye.
- The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.
- Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model.
- Efficacy of hyaluronidase in reducing increases in intraocular pressure related to the use of viscoelastic substances.
- Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual a...
- Hydroepithelial keratectomy in rabbits with a waterjet-based instrument.
- A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic co...
- Effectiveness of BION tears, Cellufresh, Aquasite, and Refresh Plus for moderate to severe dry eye.
- Atopic keratoconjunctivitis.
- Histaminase activity in patients with vernal keratoconjunctivitis.
- Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
- Effects of flurbiprofen and indomethacin on acute cystoid macular edema after Cataract surgery: functional vision and contrast sensitivity.
- Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
- Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
- Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
- Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapy.
- A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity.
- Dry eye therapy: evaluation of current directions and clinical trials.
- A scanning electron micrographic comparison of the effects of two preservative-free artificial tear solutions on the corneal epithelium as compared to a phosphate buff...
- Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.
- Complications and symptoms with disposable daily wear contact lenses and conventional soft daily wear contact lenses.
- Differential diagnosis of ocular allergic disorders.
- Complications and symptoms in disposable extended wear lenses compared with conventional soft daily wear and soft extended wear lenses.
- Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects.
- Eicosanoid modulation and epithelial wound healing kinetics of the alkali-burned cornea.
- Allergic conjunctivitis: a survey of new antihistamines.
- The level of tryptase in human tears. An indicator of activation of conjunctival mast Cells.
- Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea.
- Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis.
- Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis.
- Standard models of corneal injury using alkali-immersed filter discs.
- Dynamics of corneal epithelial healing after an alkali burn. A statistical analysis.
- The effect of hyaluronidase on akinesia during Cataract surgery.
- Standardized recording of acute corneal disease.
- Correlation between C-reactive protein and throat culture results in patients with pharyngitis.
- Factors influencing predilection and outcome in bacterial keratitis.
- Time course of human conjunctival mast Cell degranulation in response to compound 48/80.
- Characteristics of the Cellular response of the rat conjunctiva to topically applied leukotriene B4.
Schools
McGill University Faculty Of Medicine
Royal Victoria Hospital McGill
Mass Eye Ear InfrmEye Rsch
Procedures Preformed
- Cornea Transplant
Conditions Treated
- Cataract
- Giant Cell Arteritis
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- AAO Life Fellow
- ARVO Fellow
- Distinguished Alumnus Award
- Hall of Fame
- Service Award
- Honor Award
- Fellow (FAAO)
Education
-
Harvard Medical School -
Massachusetts Eye & Ear Infirmary -
McGill University Faculty of Medicine -
McGill University
Hospital
-
Massachusetts Eye and Ear Infirmary
Helpful Reviews
Similar Doctors
|
|
Dr. Gail L. Torkildsen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry J. Crampton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Latina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel D. Allen, MD |